Latent tuberculosis diagnosis in children by using the quantiFERON-TB gold in-tube test

Pediatrics

Volumn 123, Issue 1, 2009, Pages 30-37

  Lighter, Jennifer ^a   Rigaud, Mona ^a   Eduardo, Roger ^a   Peng, Chia Hui ^a   Pollack, Henry ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Children; Interferon releasing assay; Quantiferon; Tuberculosis

Indexed keywords

BCG VACCINE; GAMMA INTERFERON; PHYTOHEMAGGLUTININ;

ARTICLE; BCG VACCINATION; BLOOD ANALYSIS; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; FEMALE; HUMAN; HUMAN TISSUE; INFANT; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; TUBERCULIN TEST; TUBERCULOSIS; UNITED STATES; ANALYTICAL EQUIPMENT; BLOOD; BLOOD EXAMINATION; COMPARATIVE STUDY; DIAGNOSTIC TEST; DISEASE TRANSMISSION; EARLY DIAGNOSIS; ISOLATION AND PURIFICATION; METHODOLOGY; RISK FACTOR; STANDARD; TIME;

CHILD; CHILD, PRESCHOOL; DIAGNOSTIC TESTS, ROUTINE; EARLY DIAGNOSIS; FEMALE; HEMATOLOGIC TESTS; HUMANS; INFANT; INTERFERON-GAMMA; MALE; MYCOBACTERIUM TUBERCULOSIS; PROSPECTIVE STUDIES; REAGENT KITS, DIAGNOSTIC; RISK FACTORS; TIME FACTORS; TUBERCULIN TEST; TUBERCULOSIS;

EID: 59449102430     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2007-3618     Document Type: Article

References (30)

1. World Health Organization. Global Tuberculosis Control: Surveillance, Planning, Financing. Geneva, Switzerland: World Health Organization; 2002
2. Marais B, Gie R, Schaaf HS, Beyers N, Donald P, Starke J. Childhood pulmonary tuberculosis: old wisdom and new challenges. Am J Respir Crit Care Med. 2006;173(10):1078-1090
3. Lewinsohn D, Gennaro M, Scholvinck D. Tuberculosis immunology in children: diagnostic and therapeutic challenges and opportunities. Int J Tuberc Lung Dis. 2004;8(5):658-674
4. Huebner RE, Schein MF, Bass JB. The tuberculin skin test. Clin Infect Dis. 1993;17(6):968-975
5. Farhat M, Greenwaway C, Pai M, et al. False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculoous mycobacteria. Int J Tuberc Lung Dis. 2006;10(11): 1192-1204
6. Mori T, Sakatani M, Yamagishi F, Takashima T. Specific detection of tuberculosis infection: an interferon y based assay using new antigens. Am J Respir Crit Care Med. 2004;170(1):59-64
7. Brock I, Munk ME, Kok-Jensen A, Anderson P. Performance of whole blood IFN-γ test for tuberculosis diagnosis based on PPD or the specific antigens ESAT-6 and CRP-10. Int J Tuberc Lung Dis. 2001;5(5):462-467
8. Ferrara G, Losi M, Meacci M, et al. Routine hospital use of a new commercial whole blood interferon-γ assay for the diagnosis of tuberculosis infection. Am J Respir Crit Care Med. 2005; 172(5):631-635
9. Mazurek GH, Zajdowicz MJ, Hankinson AL, et al. Detection of Mycobacterium tuberculosis infection in United States Navy recruits using the tuberculin skin test or whole-blood interferon-γ release assays. Clin Infect Dis. 2007;45(7):826-836
10. Arend SM, Thijsen SF, Leyten EM, et al. Comparison of two interferon-γ assays and tuberculin skin test for tracing tuberculosis contacts. Am J Respir Crit Care Med. 2007;175(6):618-627
11. Mazurek G, Jereb J, LoBue P, et al. Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection: United States. MMWR Recomm Rep. 2005; 54(RR-15):49-55
12. Harris TG, Dorsinville M, Munsiff, et al. Piloting of QuantiFERON-TB Gold by the New York City Department of Health and Mental Hygiene. Presented at the First Global Symposium on Interferon-y Releasing Assays; February 21-22, 2007; Vancouver, Canada
13. Starke JR. Use of new TB test in children should be limited. AAP News. 2006;27(3):14-15
14. Centers for Disease Control and Prevention. Trends in tuberculosis incidence: United States, 2006. MMWR Morb Mortal Wkly Rep. 2007;56(11):245-250
15. Nakaoka H, Lawson L, Squire SB, et al. Risk for tuberculosis among children. Emerg Infect Dis. 2006;12(9):1383-1388
16. Tsiouris S, Austin J, Toro P, et al. Results of a tuberculosis-specific IFN-y assay in children at high risk of tuberculosis infection. Int J Tuberc Lung Dis. 2006;10(8):939-941
17. Dogra S, Narang P, Mendiratta DK, et al. Comparison of a whole blood interferon-y assay with tuberculin skin testing for the detection of tuberculosis infection in hospitalized children in rural India. J Infect. 2007;54(3):267-276
18. Detjen A, Keil T, Roll S, et al. Interferon-γ release assays improve the diagnosis of tuberculosis and nontuberculosus mycobacterial disease in children in a country with a low incidence of tuberculosis. Clin Infect Dis. 2007;45(3):322-328
19. Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med. 2007;146(5):340-354
20. Arend S. A supersize contact investigation with comparison of two IGRA. Presented at the First Global Symposium on Interferon-γ Releasing Assays; February 21-22, 2007; Vancouver, Canada
21. Mori T, Harada N, Higuchi K. Waning of the specific interferon-γ response after years of tuberculosis infection. Int J Tuberc Lung Dis. 2007;11(9):1021-1025
22. Cehovin A, Cliff JM, Hill PC, Brookes RH, Dockrell HM. Extended culture enhances sensitivity of y interferon assay for latent Mycobacterium tuberculosis infection. Clin Vaccine Immunol. 2007;14(6):796-798
23. Leyten EM, Arend SM, Prins C, Cobelens FG, Ottenhoff TH, van Dissel JT. Discrepancy between Mycobacterium tuberculosis-specific interferon-y release assays using short versus prolonged in vitro incubation. Clin Vaccine Immunol. 2007;14(7):880-885
24. Connell TB, Curtis N, Ranganathan SC, Buttery JP. Performance of a whole blood interferon γ assay for detecting latent infection with Mycobacterium tuberculosis in children. Thorax. 2006;61(7):616-620
25. Andersen P, Doherty TM, Pai M, Weldingh K. The prognosis of latent tuberculosis: can disease be predicted? Trends Mol Med. 2007;13(5):175-182
26. Vordermeier HM, Chambers MA, Cockle PJ, Whelan AO, Simmons J, Hewinson RG. Correlation of ESAT-6-specific γ inter- feron production with pathology in cattle following Mycobacterium bovis BCG vaccination against experimental bovine tuberculosis. Infect Immun. 2002;70(6):3026-3032
27. Buddle BM, Parlane NA, Keen DL, et al. Differentiation between Mycobacterium bovis BCG-vaccinated and M bovis-infected cattle by using recombinant mycobacterial antigens. Clin Diagn Lab Immunol. 1999;6(1):1-5
28. Doherty TM, Demissie A, Olobo J, et al. Immune responses to the Mycobacterium tuberculosis-specific antigen ESAT-6 signal subclinical infection among contacts of tuberculosis patients. J Clin Microbiol. 2002;40(2):704-706
29. Demissie A, Abebe M, Aseffa A, et al. Healthy individuals that control a latent infection with Mycobacterium tuberculosis express high levels of Th1 cytokines and the IL-4 antagonist IL-4δ2. J Immunol. 2004;172(11):6938-6943
30. Diel R, Loddenkemper R, Meywald-Walter K, Niemann S, Nienhaus A. Predictive value of whole-blood IFN-γ assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis. Am J Respir Crit Care Med. 2008;177(10):1164-1170